CTRI/2020/09/028141招募中1 期
â??Safety, Tolerability and Sensory Evaluation of HQIS-101904 in Healthy Adult Volunteers, An Open-Label Single-Arm Clinical Studyâ??
试验速览
- 阶段
- 1 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Healthy adult volunteers of either sex aged between >=18 to <=50 years.
- •2. Subjects willing to sign informed consent and follow the study
- •3. Has not participated in a similar investigation in the past four weeks.
- •4. Subjects willing to refrain taking any other nutritional supplement
- •during the study period
排除标准
- •1. Subjects with clinically significant serious cardiovascular,
- •cerebrovascular, respiratory, liver,
- •renal disease, congenital or any other disorder.
- •2. A known history or present condition of allergic response to
- •pharmaceutical products its
- •components or ingredients in the test product.
- •3. Pre-existing systemic disease necessitating long-term
- •medications.
- •4. Genetic and endocrinal disorders.
- •5. Subjects who refused to sign informed consent.
- •6. Pregnant and lactating women
研究者
相似试验
尚未招募
1 期
Phase I safety Evaluation of HQMZ111831 in Healthy Female VolunteersCTRI/2019/03/017991The Himalaya Drug Company
尚未招募
1 期
Phase I safety study of HQAP061801 in Healthy Adult VolunteersCTRI/2019/03/017972The Himalaya Drug Company
尚未招募
1 期
Evaluation of safety, tolerability of Mentat Syrup in healthy peopleCTRI/2022/04/041683Himalaya Wellness Company
尚未招募
1 期
Evaluating the safety of Liv.52 SS SF syrup in healthy volunteersCTRI/2022/10/046467Himalaya Wellness Company
尚未招募
1 期
Evaluation of safety, tolerability of Septilin Syrup in healthy people.CTRI/2022/04/041811Himalaya Wellness Company